Intradermally Administered Yellow Fever Vaccine at Reduced Dose Induces a Protective Immune Response: A Randomized Controlled Non-Inferiority Trial

Anna H. Roukens, Ann C. Vossen, Peter J. Bredenbeek et al. · 2008

Read Intradermally Administered Yellow Fever Vaccine at Reduced Dose Induces a Protective Immune Response: A Randomized Controlled Non-Inferiority Trial by Anna H. Roukens, Ann C. Vossen, Peter J. Bredenbeek et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001993.txt.

Description

Anna Roukens and co-authors tested a smaller dose of yellow fever vaccine, in a 2008 PLOS ONE study. Yellow fever vaccination is held back by short supply of the vaccine. Giving each person less, if it still protects, would stretch stocks across far more people.

The team tried a new route: injecting a reduced dose into the skin, rather than under it. Their randomized trial was built as a non-inferiority test. It was meant to prove the low dose is not worse than the standard by more than a set margin. As the title states, the reduced dose induced a protective immune response.

Catalog record

CREATORAnna H. Roukens, Ann C. Vossen, Peter J. Bredenbeek et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001993

Browse the full library · About the Tower of Babel